For: | Guo J, Yang P, Li YF, Tang JF, He ZX, Yu SG, Yin HY. MicroRNA: Crucial modulator in purinergic signalling involved diseases. Purinergic Signal 2023;19:329-41. [PMID: 35106737 DOI: 10.1007/s11302-022-09840-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Tang Y, Chen JF, Illes P. Editorial: Purinergic signalling - a perspective from China. Purinergic Signal 2023;19:1-3. [PMID: 36515791 DOI: 10.1007/s11302-022-09914-x] [Reference Citation Analysis] |
2 | Göllner S, Müller-tidow C. AKTing on XPO1 inhibition in AML. Nat Cancer 2022;3:787-789. [DOI: 10.1038/s43018-022-00395-w] [Reference Citation Analysis] |
3 | Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis] |